CIS
ORGO icon

Connors Investor Services’s Organogenesis Holdings ORGO Stock Holding History

Connors Investor Services’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-70,000
Closed -$196K – 167
2024
Q2 		$196K Buy
70,000
+2,000
+3% +$5.37K 0.02% 140
2024
Q1 		$193K Buy
68,000
+25,000
+58% +$85K 0.02% 148
2023
Q4 		$176K Buy
+43,000
New +$120K 0.02% 146

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connors Investor Services's ORGO Position: Q3 2024 in Review

Connors Investor Services sold out of Organogenesis Holdings (ORGO) in Q3 2024, closing a stake of 70,000 shares — an estimated $196K sold.

Connors Investor Services first reported a position in ORGO in Q4 2023 and held it in 3 quarters. The position peaked at $196K in Q2 2024. 112 funds tracked by Wall St. Rank hold ORGO as of Q3 2024.

  • Connors Investor Services reported no remaining Organogenesis Holdings position as of Q3 2024 after selling out during the quarter.
  • Connors Investor Services sold 70,000 Organogenesis Holdings shares in Q3 2024, an estimated $196K.
  • Connors Investor Services first reported a position in Organogenesis Holdings in Q4 2023 and held it in 3 quarters.
  • Connors Investor Services's Organogenesis Holdings position peaked at $196K in Q2 2024.
  • 112 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2024.

Based on Connors Investor Services's 13F filing for Q3 2024, filed 14 Nov 2024.